- Dr Hobbs’ personal experience with diabetes
- What the approval of Fiasp® means to him as a person with type 1 diabetes
- How Fiasp® dose timing is different and what that means for adults with diabetes
The Vice President and Chief Medical Officer for Novo Nordisk shares his personal experience with diabetes and why Fiasp® may be an option for adults with diabetes needing mealtime insulin today.
Fiasp® (insulin aspart injection) 100 U/mL is a rapid-acting insulin analog indicated to improve glycemic control in adults with diabetes mellitus.
Please click here for Prescribing Information.